Cargando...
Mechanisms, monitoring, and management of tyrosine kinase inhibitors–associated cardiovascular toxicities
The tyrosine kinase inhibitor (TKI) drug class is a prominently used option in the treatment of various cancers. Safety evaluation of these drugs has shown evidence of cardiotoxicity of varying frequency and severity between agents; concern has led to updated labeling, warning prescribers of such. T...
Guardado en:
| Publicado en: | Onco Targets Ther |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6163027/ https://ncbi.nlm.nih.gov/pubmed/30288058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S170138 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|